Antidepressant treatment in patients following acute coronary syndromes: a systematic review and Bayesian

Romy Sweda1,2, George C M Siontis1, Adriani Nikolakopoulou3

  • 1Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, CH-3010, Switzerland.

ESC Heart Failure
|September 16, 2020
PubMed

Insights

Antidepressant therapy after acute coronary syndrome (ACS) does not impact mortality but reduces hospitalizations. For ACS patients with depression, antidepressants lower the risk of recurrent myocardial infarction.

Area of Science:

  • Cardiology
  • Psychiatry
  • Pharmacology

Background:

  • Acute coronary syndrome (ACS) is a critical cardiovascular event.
  • Depression is a common comorbidity in ACS patients, impacting outcomes.
  • The role of antidepressant therapy in managing ACS patients is under investigation.

Purpose of the Study:

  • To evaluate the impact of antidepressant therapy on mortality and cardiovascular outcomes in patients post-ACS.
  • To assess the efficacy of antidepressants in reducing all-cause mortality, repeat hospitalizations, and recurrent myocardial infarctions (MIs).

Main Methods:

  • A systematic search of PubMed, Embase, and Cochrane Central Register was conducted.
  • Bayesian random-effects meta-analysis of 10 randomized controlled trials (1935 patients) was performed.
  • Primary outcome: all-cause mortality. Secondary outcomes: repeat hospitalizations and recurrent MIs.

Main Results:

  • Antidepressant therapy showed no significant effect on all-cause mortality (OR 0.97, 95% CrI 0.66-1.42) or recurrent MI (OR 0.64, 95% CrI 0.40-1.02).
  • A significant reduction in repeat hospitalizations was observed with antidepressant use (OR 0.62, 95% CrI 0.40-0.94).
  • In ACS patients with depression, antidepressants significantly reduced the odds of recurrent MI (OR 0.45, 95% CrI 0.25-0.81).

Conclusions:

  • Antidepressants do not influence mortality rates in patients following ACS.
  • Antidepressant therapy is associated with a decrease in repeat hospitalizations post-ACS.
  • For ACS patients experiencing depression, antidepressant treatment offers a reduced risk of recurrent myocardial infarction.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
132
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
652
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
119
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.1K
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
167